{"id":"W2318415095","doi":"10.1186/s40064-016-2008-9","title":"Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice","year":2016,"lang":"en","type":"article","venue":"SpringerPlus","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"U.S. Navy; Genentech; U.S. Department of Defense","keywords":"Trastuzumab; Medicine; Adjuvant; Breast cancer; Clinical Practice; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000973684,0.0002490855,0.0006403439,0.0002505278,0.00002787919,0.00001924793,0.0001640375,0.00008604384,0.000273202],"category_scores_gemma":[0.0003594643,0.0001388599,0.00004754215,0.0006564023,0.000200473,0.0002264016,0.00006031013,0.000511395,0.00007129119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009067454,"about_ca_system_score_gemma":0.0009881193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003513362,"about_ca_topic_score_gemma":0.00360195,"domain_scores_codex":[0.9970367,0.0002394895,0.0005861188,0.0005863511,0.0009031155,0.0006482477],"domain_scores_gemma":[0.9982851,0.0004620849,0.0001566994,0.0004945917,0.0003170943,0.000284456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00768816,0.0009965827,0.9078894,0.00007429215,0.0001018765,0.0004826406,0.0001430321,0.000009231286,0.00005349767,0.000006295046,0.00006820268,0.08248677],"study_design_scores_gemma":[0.01775372,0.001598328,0.9778506,0.001377468,0.00007761041,0.00002903915,0.000111801,0.00004646655,0.00006771943,0.000001927726,0.0008711235,0.000214173],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951356,0.00007631219,0.00007495136,0.001858028,0.0001201841,0.001004597,0.00005319263,0.00003529012,0.001641856],"genre_scores_gemma":[0.9982046,0.0001328392,0.0008611356,0.0001362788,0.0001055608,0.0001381214,0.000006039535,0.00006794023,0.0003474133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0822726,"threshold_uncertainty_score":0.5662541,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02936261070029393,"score_gpt":0.3779138114276678,"score_spread":0.3485512007273739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}